Ion-pair reversed-phase HPLC: Assay validation of sodium tanshinone IIA sulfonate in mouse plasma

被引:22
作者
Mao, SJ
Hou, SX
Liang, Z
Bi, YQ
Wu, Y
Li, H
Jin, H
机构
[1] Sichuan Univ, W China Sch Pharm, Chengdu 610041, Peoples R China
[2] Peoples Hosp Sichuan Prov, Dept Hematol, Chengdu 610072, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2006年 / 831卷 / 1-2期
关键词
sodium tanshinone IIA sulfonate (STS); ion-pair; reversed-phase HPLC; pharmacokinetics;
D O I
10.1016/j.jchromb.2005.11.045
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Sodium tanshinone IIA sulfonate (STS), a hydrophilic ionic substance, is used as a cardiovascular drug. An ion-pair reversed-phase high-performance liquid chromatography (IP-RP-HPLC) method for the determination of STS in mouse plasma was initially developed. The assay involved a rapid and simple extraction process and subsequent detection at 271 nm. The retention time for STS was 7.5 min. Based on extracted STS standard mouse plasma at 1.5, 10 and 50 mu g/ml, the assay precision were 2.7, 2.1 and 1.7% with a mean accuracy of 96.7, 98.5 and 99.4%, respectively, At plasma concentration of 1.5, 50 and 75 mu g/ml, the mean recovery of STS were 93.1, 96.3 and 97.5%. The limit of detection (LOD) and limit of quantification (LOQ) for STS was 0.1 mu g/ml and 0.5 mu g/ml, respectively. Linear responses were observed over a wide concentration range (0.5-100 mu g/ml) for STS in mouse plasma. STS can be detected after intravenous administration. This method was performed for the first time in pharmacokinetic studies of STS in the mouse. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:163 / 168
页数:6
相关论文
共 15 条
[1]   Trisomy 13 mosaicism: study of serial cytogenetic changes in a case from early pregnancy to infancy [J].
Chen, M ;
Yeh, GP ;
Shih, JC ;
Wang, BT .
PRENATAL DIAGNOSIS, 2004, 24 (02) :137-143
[2]  
Chen WZ, 1979, ACTA PHARMACOL SINIC, V14, P277
[3]  
CHIEN MK, 1978, ACTA CHIM SINICA, V36, P199
[4]  
HONDA G, 1988, CHEM PHARM BULL, V36, P408
[5]  
Jiang KY, 1998, ACTA PHARMACOL SIN, V19, P47
[6]  
[刘刚 Liu Gang], 2004, [中国药学杂志, Chinese Pharmaceutical Journal], V39, P218
[7]   Sodium tanshinone IIA sulfonate derived from Danshen (Salvia miltiorrhiza) attenuates hypertrophy induced by angiotensin II in cultured neonatal rat cardiac cells [J].
Takahashi, K ;
Ouyang, X ;
Komatsu, K ;
Nakamura, N ;
Hattori, M ;
Baba, A ;
Azuma, J .
BIOCHEMICAL PHARMACOLOGY, 2002, 64 (04) :745-750
[8]   EFFECT OF SODIUM TANSHINONE IIA SULFONATE IN THE RABBIT MYOCARDIUM AND ON HUMAN CARDIOMYOCYTES AND VASCULAR ENDOTHELIAL-CELLS [J].
WU, TW ;
ZENG, LH ;
FUNG, KP ;
WU, J ;
PANG, H ;
GREY, AA ;
WEISEL, RD ;
WANG, JY .
BIOCHEMICAL PHARMACOLOGY, 1993, 46 (12) :2327-2332
[9]  
Xue Ming, 1999, Yaoxue Xuebao, V34, P81
[10]  
ZHANG J, 2000, J LUZHOU MED COLL, V23, P177